Penwest Pharmaceuticals Co, Inc.

To become the high growth preeminent provider of innovative oral drug delivery technologies and products to the global pharmaceutical industry

Penwest is engaged in the research, development and commercialization of novel oral drug delivery technologies and has extensive expertise in developing and manufacturing functional ingredients. The Company's PROSOLV Technology improves tablet manufacturability and provides the opportunity to enhance dosage forms that elevate patient compliance. The TIMERx controlled release technology creates therapeutically enhanced medicines to improve patient care.